Follow-The-Filings

Security · featured owners

MAZE Maze Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.4%
  • $35M
  • 2 add

MAZE (Maze Therapeutics Inc.) is held in 2 featured 13F books as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (0.37%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel Add 0.37%
  2. Farallon Capital Management Add 0.15%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management 2026 Q2 0.15% Add +197.0% 1,107,814 $33M History
Nathan Fischel - Dafna Capital Management 2026 Q2 0.37% Add +85.7% 65,000 $2M History

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 4, 2026 Filing Doc
4 Period Sep 2, 2026 · 4 forms Filing Doc
4 Period Sep 1, 2026 · 4 forms Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Aug 13, 2026 · 2 forms Filing Doc
4 Period Aug 13, 2026 Filing Doc
4 Period Aug 3, 2026 Filing Doc
4 Period Jul 29, 2026 Filing Doc
4 Period Jul 1, 2026 · 2 forms Filing Doc
4 Period Jun 29, 2026 Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 8, 2026 · 6 forms Filing Doc

Updated 17 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2025
Net income -$131.12M

Balance sheet

Metric FY2025
Total current assets $349.72M
Total non-current assets * $47.41M
Total assets $397.13M
Total current liabilities $22.56M
Total non-current liabilities * $19.6M
Total equity $354.97M

Cash flow

Metric FY2025
Cash from operations -$111.94M
Cash from investing -$170.96M
Cash from financing $275.34M
Net change in cash * -$7.56M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders